IL110117A0 - Pharmaceutical compositions comprising vitamin-d analogs - Google Patents

Pharmaceutical compositions comprising vitamin-d analogs

Info

Publication number
IL110117A0
IL110117A0 IL11011794A IL11011794A IL110117A0 IL 110117 A0 IL110117 A0 IL 110117A0 IL 11011794 A IL11011794 A IL 11011794A IL 11011794 A IL11011794 A IL 11011794A IL 110117 A0 IL110117 A0 IL 110117A0
Authority
IL
Israel
Prior art keywords
analogs
vitamin
pharmaceutical compositions
pharmaceutical
compositions
Prior art date
Application number
IL11011794A
Original Assignee
Univ Ben Gurion
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Ben Gurion filed Critical Univ Ben Gurion
Priority to IL11011794A priority Critical patent/IL110117A0/en
Publication of IL110117A0 publication Critical patent/IL110117A0/en
Priority to AU29980/95A priority patent/AU2998095A/en
Priority to PCT/US1995/008005 priority patent/WO1996000074A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
IL11011794A 1994-06-24 1994-06-24 Pharmaceutical compositions comprising vitamin-d analogs IL110117A0 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IL11011794A IL110117A0 (en) 1994-06-24 1994-06-24 Pharmaceutical compositions comprising vitamin-d analogs
AU29980/95A AU2998095A (en) 1994-06-24 1995-06-22 Pharmaceutical compositions comprising vitamin-d analogs
PCT/US1995/008005 WO1996000074A1 (en) 1994-06-24 1995-06-22 Pharmaceutical compositions comprising vitamin-d analogs

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IL11011794A IL110117A0 (en) 1994-06-24 1994-06-24 Pharmaceutical compositions comprising vitamin-d analogs

Publications (1)

Publication Number Publication Date
IL110117A0 true IL110117A0 (en) 1994-10-07

Family

ID=11066274

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11011794A IL110117A0 (en) 1994-06-24 1994-06-24 Pharmaceutical compositions comprising vitamin-d analogs

Country Status (3)

Country Link
AU (1) AU2998095A (en)
IL (1) IL110117A0 (en)
WO (1) WO1996000074A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
FR2759586B1 (en) * 1997-02-20 2000-01-14 Paul Trouillas ANTI-CANCER TYPE DRUG COMPRISING AT LEAST AS THE ACTIVE INGREDIENT OF 1-ALPHA HYDROXYCALCIFEROL OR ALFACALCIDOL
CA2326117A1 (en) 1998-03-27 1999-10-07 Oregon Health Sciences University Vitamin d and its analogs in the treatment of tumors and other hyperproliferative disorders
KR100438254B1 (en) * 2001-03-29 2004-07-02 아이큐어 주식회사 Matrix form of preparation for transdermal administration of vitamin d analog
US20050256092A1 (en) * 2002-08-01 2005-11-17 Shin Shimaoka Antipsoriatic agent
AU2002368245A1 (en) * 2002-09-26 2004-04-19 Young-Kweon Choi Matrix type patch for transdermal administration of vitamin d analog and the use thereof
US9173835B2 (en) * 2005-05-10 2015-11-03 Dermipsor Ltd. Compositions and methods for treating hyperproliferative epidermal diseases
CA2640094C (en) 2006-02-03 2015-04-14 Proventiv Therapeutics, Llc Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
ES2670029T3 (en) 2006-06-21 2018-05-29 Opko Ireland Global Holdings, Ltd. Therapy using vitamin D replenishment agent and vitamin D hormone replacement agent
US10265265B2 (en) * 2007-03-15 2019-04-23 Drug Delivery Solutions Limited Topical composition
EP3335712A1 (en) 2007-04-25 2018-06-20 Opko Renal, LLC Method of safely and effectively treating and preventing secondary hyperparathyroidism in chronic kidney disease
WO2008134518A2 (en) 2007-04-25 2008-11-06 Cytochroma Inc. Methods and compounds for vitamin d therapy
CN101668532B (en) 2007-04-25 2014-08-20 赛特克罗公司 Composition for treating vitamin d insufficiency and deficiency, secondary hyperparathyroidism and vitamin D responsing diseases and corresponding pharmaceutical purposes
JP5501956B2 (en) 2007-04-25 2014-05-28 シトクロマ インコーポレイテッド Controlled release oral composition containing a vitamin D compound and a waxy carrier
US8962239B2 (en) 2008-04-02 2015-02-24 Opko Renal, Llc Methods useful for vitamin D deficiency and related disorders
KR102125424B1 (en) 2010-03-29 2020-06-22 사이토크로마 인코포레이티드 Methods and compositions for reducing parathyroid levels
HUE045467T2 (en) 2011-03-14 2020-01-28 Drug Delivery Solutions Ltd An ophthalmic composition
KR101847947B1 (en) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 Stabilized modified release vitamin d formulation
US20160008377A1 (en) * 2014-07-12 2016-01-14 Aphios Corporation Formulations and compositions of vitamin d analogs for treating and preventing cancer and other diseases
AU2015298858A1 (en) 2014-08-07 2017-03-02 Opko Ireland Global Holdings Ltd. Adjunctive therapy with 25-hydroxyvitamin D
BR112018069727A2 (en) 2016-03-28 2019-02-05 Opko Ireland Global Holdings Ltd vitamin d treatment methods
EP3542788A1 (en) 2018-03-19 2019-09-25 MC2 Therapeutics Limited Topical composition comprising calcipotriol and betamethasone dipropionate

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU5185790A (en) * 1989-02-16 1990-09-05 University Of Georgia Research Foundation, Inc., The Treatment of tibial dyschondroplasia
KR960013798B1 (en) * 1992-04-24 1996-10-10 재단법인 한국전자통신연구소 Optic switch

Also Published As

Publication number Publication date
AU2998095A (en) 1996-01-19
WO1996000074A1 (en) 1996-01-04

Similar Documents

Publication Publication Date Title
IL110117A0 (en) Pharmaceutical compositions comprising vitamin-d analogs
ZA957247B (en) Pharmaceutical compositions
IL104068A0 (en) Pharmaceutical compositions for inhalation
HU9503199D0 (en) Pharmaceutical basic compositions
ZA967827B (en) Pharmaceutical compositions
IL119080A0 (en) Pharmaceutical compositions containing tramadol
HUT74746A (en) Pharmaceutical compositions containing p antagonist
IL113329A0 (en) Benzamide-containing pharmaceutical compositions
GB9418609D0 (en) Pharmaceutical compositions
EG24294A (en) Pharmaceutical compositions
GB9506382D0 (en) Pharmaceutical compositions
HU9500618D0 (en) Oral pharmaceutical compositions
ZA96525B (en) Novel pharmaceutical compositions
GB9513972D0 (en) Pharmaceutical compositions
ZA954469B (en) Pharmaceutical compositions
GB9406835D0 (en) Pharmaceutical compositions
GB2295825B (en) Pharmaceutical compositions
ZA959081B (en) Pharmaceutical compositions
HU9601821D0 (en) Pharmaceutical compositions
HU9400096D0 (en) Pharmaceutical compositions
GB2285923B (en) Pharmaceutical compositions containing N-acetal-cysteine
GB2308545A (en) Pharmaceutical compositions
GB9406121D0 (en) Pharmaceutical compositions
GB9413072D0 (en) Pharmaceutical compositions
GB9405948D0 (en) Pharmaceutical compositions